Brief: Huadong Medicine In Strategic Cooperation With Heidelberg Pharma AG
Feb 28 (Reuters) - Huadong Medicine Co Ltd 000963.SZ :
* SAYS IT SIGNS STRATEGIC COOPERATION AGREEMENT WITH
HEIDELBERG
PHARMA AG
* SAYS HONG KONG UNIT SIGNS AGREEMENT TO INVEST 105 MILLION
EUROS
($117.45 million) FOR 35% STAKE IN HEIDELBERG PHARMA, PENDING
AUTHORITIES' APPROVAL
Source text http://www.szse.cn/disclosure/listed/bulletinDetail/index.html?1b20070e-9d4b-4721-bf99-5d718515d17f
Further company coverage: 000963.SZ
($1 = 0.8940 euros)
(Reporting by Hong Kong newsroom)
((twinnie.siu@tr.com; 852-3462 7715;))
Recent news on Heidelberg Pharma AG
See all newsBrief: Heidelberg Pharma Says Co. And Healthcare Royalty Announce Amendment To Existing Royalty Agreement
Brief: Redhill Biopharma Secures Allowance Of Key Chinese Patent Application For Proprietary COVID-19 Treatment, RHB-107
Brief: Heidelberg Pharma Amends Royalty Financing With Healthcare Royalty
Brief: Heidelberg Pharma Expects FY EBIT Between EUR -19 Mln And EUR -22 Mln
Brief: Heidelberg Pharma AG: Announces Updated Guidance